Tag: Gore

CX 2019: VBX set to be a “game-changer” for treating complex...

𝙏𝙝𝙞𝙨 𝙫𝙞𝙙𝙚𝙤 𝙞𝙨 𝙞𝙣𝙩𝙚𝙣𝙙𝙚𝙙 𝙛𝙤𝙧 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙞𝙣 𝙀𝙪𝙧𝙤𝙥𝙚 𝙤𝙣𝙡𝙮. Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and...

First US patient receives Gore TAG conformable thoracic stent graft with...

Gore has announced the first US implant of its Gore TAG conformable thoracic stent graft with ACTIVE CONTROL system. The successful procedure was performed...

Gore receives FDA approval for the Gore TAG conformable thoracic stent...

Gore has announced that the US Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution for the Gore TAG Conformable Thoracic...

EVAR with an iliac branch endoprothesis is safe and effective

On Wednesday, during the Aortic Podium 1st session at Charing Cross (CX) Symposium, Fabio Verzini (Turin, Italy) reported that endovascular aneurysm repair (EVAR) with...

Gore Tigris vascular stent demonstrates high patency rates at 12 months

New results suggest that the Tigris vascular stent (Gore) is a safe and effective device that can be incorporated into a modern “leave-nothing-behind” treatment...

Gore introduces GORE TAG Conformable Thoracic Stent Graft with reduced profiles...

  Gore has introduced reduced profiles for the most commonly used diameters of the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile...

First patient in Europe receives implant of Gore Excluder Conformable AAA...

  Gore has announced the first European patient implant of the Gore Excluder Conformable AAA Endoprosthesis with Active Control System. This next-generation endovascular aneurysm repair...

Gore announces successful patient implant of endovascular stent graft for the...

Gore have announced the first implant in conjunction with the Gore ARISE study of the Gore Ascending Stent Graft, an investigational device and the...

Gore moulding and occlusion balloon for endovascular aortic repair receives approval...

Gore has announced FDA 510(k) clearance, approval from the Japanese Ministry of Health, Labour, and Welfare, and receipt of CE mark for the innovative...

First commercial in-human use of Gore TAG Conformable Thoracic Stent Graft...

The first patient has been implanted with the Gore TAG Conformable Thoracic Stent Graft with Active Control System after being included on the Australian...

Two-year data from Viabahn BX IDE trial “promising”

The 24-month data from the Viabahn BX Flex balloon-expandable stent (Gore) investigational device exemption (IDE) trial are “promising” with sustained clinical and patency benefits...

First patient enrolled in investigational study of the Gore Excluder Conformable...

  Gore has announced the first implant of the Gore Excluder Conformable abdominal aortic aneurysms (AAA) endoprosthesis in the USA. The procedure took place on...

First patient enrolled in registry for the Gore TAG Conformable stent...

Gore has announced the first patient enrolment in its post-market European registry for the Gore TAG Conformable Thoracic Stent Graft with Active Control System, following...

First-in-human use TEVAR of Gore TAG thoracic stent graft with Active...

Gore has announced the first patient implant of the TAG conformable thoracic stent graft with Active Control system after the receipt of CE mark...

Excluder Iliac Branch Endoprosthesis device meets mid-term primary endpoints in clinical...

At the 2017 Vascular Annual Meeting (VAM; 30 May–3 June, San Diego, USA), mid-term follow-up data from a pivotal trial (IBE 12-04) of the...

Gore receives regulatory approval for Excluder iliac branch endoprosthesis in Japan

Gore has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare to market the Excluder iliac branch endoprosthesis (IBE), and is...

Tigris stent gets Health Canada approval for peripheral artery disease

Gore has announced the Health Canada approval of the Tigris vascular stent, a dual-component stent with a unique fluoropolymer/nitinol design. The device, which gained...

First implant of Viabahn VBX stent graft completed

Houston Methodist Hospital has become the first US institution to implant the newly FDA-approved Viabahn VBX balloon expandable endoprosthesis (VBX stent graft; Gore), to...

US FDA approves Gore Viabahn expandable stent graft for iliac artery...

The Gore Viabahn VBX balloon expandable endoprosthesis has received US Food & Drug Administration (FDA) approval for treatment of de novo or restenotic lesions found...

Acute Dissections Symposium: “The Great Masquerader”

The best management of type B aortic dissection is an ongoing debate. In April 2016, W. L. Gore & Associates held a two-day symposium...

Gore joins vascular and endovascular leaders in recognising the 2016 Pioneers...

Gore joined with leaders across the vascular and endovascular community in honouring five North American physicians as Pioneers in Performance. The biennial awards programme acknowledges...

VEITH 2016: Enrolment completed in Gore Global registry

At the 2016 VEITHsymposium (15–19 November, New York, USA), Gore announced that the completion of target enrolment in GREAT (Global registry for endovascular aortic...

TIGRIS trial finds no stent fractures and positive primary patency in...

Twenty-four month TIGRIS trial follow-up data show that treatment using the Tigris nitinol stent (Gore) for long lesions in the superficial femoral and popliteal...

New technology add-on payment awarded for Gore Excluder iliac branch endoprosthesis

The US Centers for Medicare and Medicaid Services (CMS) has granted the Gore Excluder iliac branch endoprosthesis (IBE) new technology status. Beginning on 1...

One-year Japanese results support use of the Viabahn endoprosthesis to treat...

Gore has announced positive results from a prospective, multicentre investigational device exemption (IDE) clinical study of the Viabahn endoprosthesis with heparin bioactive surface in...

First implant completed in pivotal study of Gore TAG thoracic branch...

The first implant of Gore’s TAG thoracic branch endoprosthesis has been completed as part of the device’s pivotal study. The patient was enrolled by...

Iliac branch device results show value of internal iliac artery revascularisation

The new Excluder iliac branch endoprosthesis (Gore) is safe and effective at treating aortoiliac aneurysms and common iliac artery aneurysms, maintaining blood flow into...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....

Total endovascular repair of zone 2 aortic arch aneurysms can be...

One-year outcomes of a prospective, non-randomised, feasibility trial evaluating the treatment of aneurysms involving the proximal descending thoracic aorta indicate that total repair can...

Gore DrySeal Flex introducer sheath now commercially available

Gore has announced the commercial availability of the Gore DrySeal Flex introducer sheath, after recently gaining clearance for use by regulatory bodies in the...

Gore Tigris vascular stent gains FDA approval for treatment of peripheral...

Gore has announced US Food and Drug Administration (FDA) approval of the Gore Tigris vascular stent, a dual-component stent with a unique fluoropolymer/nitinol design....

CE mark granted to Gore Excluder conformable AAA prosthesis

Gore has received CE mark for its Excluder conformable abdominal aortic aneurysm (AAA) device, a product designed for the treatment of abdominal aortic aneurysms...